Benefits of progestin contraception in non-allergic angioedema

Clinical and Experimental Allergy

Volumn 43, Issue 4, 2013, Pages 475-482

  Saule, C ^a   Boccon Gibod, I ^b   Fain, O ^b,c   Kanny, G ^b,d   Plu Bureau, G ^a   Martin, L ^b,e   Launay, D ^b,f   Bouillet, L ^b   Gompel, A ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL JEAN VERDIER   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

C1 inhibitor; Combined pill; Estrogen; Factor XII; IUDs; Kinin; L Norgestrel IUD; Progestin only pill

Indexed keywords

ANTIGONADOTROPIC PROGESTIN; CONTRACEPTIVE AGENT; DANAZOL; ESTROGEN; GESTAGEN; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; BLEEDING; BODY WEIGHT; CONTRACEPTION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HYPERANDROGENISM; IDIOPATHIC DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PANCREATITIS; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; PUBERTY; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT RESPONSE; VEIN THROMBOSIS;

ADOLESCENT; ADULT; ANGIOEDEMAS, HEREDITARY; CONTRACEPTIVE AGENTS; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PROGESTINS; PUBERTY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875521141     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12055     Document Type: Article

References (38)

1. Agostoni A, Aygören-Pürsün E, Binkley KE et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114:S51-131.
2. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000; 356:213-7.
3. Cichon S, Martin L, Hennies HC et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 2006; 79:1098-104.
4. Binkley KE, Davis A. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000; 106:546-50.
5. Martin L, Degenne D, Toutain A, Ponard D, Watier H. Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. J Allergy Clin Immunol 2001; 107:747-8.
6. Bork K, Wulff K, Hardt J, Witzke G, Staubach P. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol 2009; 12:129-34.
7. Vitrat-Hincky V, Gompel A, Dumestre-Perard C et al. Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 2010; 65:1331-36.
8. Chen LM, Chung P, Chao S, Chao L, Chao J. Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochim Biophys Acta 1992; 1131:145-51.
9. Murray SR, Chao J, Lin FK, Chao L. Kallikrein multigene families and the regulation of their expression. J Cardiovasc Pharmacol 1990; 15(Suppl 6):S7-16.
10. Citarella F. MS, Felici A, Farsetti A, Pontecorvi A FA, Estrogen induction and contact phase activation of human factor XII. Steroids 1996; 61:270-76.
11. Farsetti A, Misiti S, Citarella F et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology 1995; 136:5076-83.
12. Falus A, Feher KG, Walcz E et al. Hormonal regulation of complement biosynthesis in human cell lines-I. Androgens and gamma-interferon stimulate the biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2. Mol Immunol 1990; 27:191-5.
13. Madeddu P, Emanueli C, Song Q et al. Regulation of bradykinin B2-receptor expression by oestrogen. Br J Pharmacol 1997; 121:1763-9.
14. Hoem NO, Johannesen S, Hauge G, Rud AC, Sandem S, Briseid K. Contact activation factors in plasma from women using oral contraceptives-increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein. Thromb Res 1991; 64:427-34.
15. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003; 114:294-8.
16. Bouillet L, Longhurst H, Boccon-Gibod I et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 2008; 199:484 e1-4.
17. André F, Veysseyre-Balter C, Rousset H, Descos L, André C. Exogenous oestrogen as an alternative to food allergy in the aetiology of angioneurotic oedema. Toxicology 2003; 185:155-160.
18. Wautier JL, Caen JP. Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema. Presse Med 1986; 15:2023.
19. Laurent J, Jamin C, Lagrue G. Hereditary angioneurotic edema: norgestrienone is not effective in every case. Presse Med 1987; 16:2132.
20. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill. Eur J Contracept Reprod Health Care 1998; 3:169-78.
21. Julkunen HA. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE. Scand J Rheumatol 1991; 20:427-33.
22. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 2010; 31:407-14.
23. McGlinchey PG, McCluskey DR. Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman. Am J Med Sci 2000; 320:212-3.
24. Caballero T, Farkas H, Bouillet L et al. C-1-INH Deficiency Working Group. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol 2012; 129:308-20.
25. Bowen T, Cicardi M, Bork K et al. Hereditary angiodema: a current state-of-the-art review, VII: canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008; 100:S30-40.
26. Barton M, Cremer J, Mugge A. 17Beta-estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries. Eur J Pharmacol 1998; 362:73-6.
27. Frederiksen MC. Depot medroxyprogesterone acetate contraception in women with medical problems. J Reprod Med 1996; 41:414-8.
28. Curtis KM, Jamieson DJ, Peterson HB, Marchbanks PA. Adaptation of the WHO's Criteria for contraceptive use for use in the United States. Contraception 2010; 82:3-9.
29. van Hylckama Vlieg A, Helmerhorst FM, Rosendaal FR. The Risk of Deep Venous Thrombosis Associated With Injectable Depot-Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device. Arterioscler Thromb Vasc Biol 2010; 30:2297-300.
30. Amar L. Kahn JE, Cordoliani F, Frémeaux-Bacchi V, Dragon-Durey MA, Chauveheid MP, Blétry O. Hereditary angio-oedema: effective treatment with the progestogen-only pill in a young woman. Br J Dermatol 2004; 151:713-4.
31. Poulter NR, Chang CL, Farley TM, Meirik O. Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications. Lancet 1999; 354:1610.
32. Gompels MM, Lock RJ, Abinun M et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139:379-94.
33. Conard J, Plu-Bureau G, Bahi N, Horellou M-H, Pelissier C, Thalabard J-C. Progestogen-only contraception in women at high risk of venous thromboembolism. Contraception 2004; 70:437-41.
34. Chabbert-Buffet N, Amoura Z, Scarabin P-Y et al. Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients. Contraception 2011; 83:229-37.
35. Gompel A, Carpentier S, Francès C, Piette J-C. Risk of venous thromboembolism and oral contraceptives. Lancet 2002; 359:1348-9.
36. Cilia La Corte AL, Carter AM, Turner AJ, Grant PJ, Hooper NM. The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill. J Renin Angiotensin Aldosterone Syst 2008; 9:221-5.
37. Teoh H, Man RY. Progesterone modulates estradiol actions: acute effects at physiological concentrations. Eur J Pharmacol 1999; 378:57-62.
38. Bork K, Gül D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med 2007; 120:987-92.